Max George

Max George is a seasoned professional in investor relations and healthcare communications, currently serving as a Senior Associate in Investor Relations at Pfizer since January 2025. Prior to this role, Max held the position of Editor for Healthcare & Life Sciences at Weber Shandwick from November 2022 to December 2024 and served as a Senior Associate in Growth & Business Development at The Daybreak Health Group from June 2020 to September 2022, where Max also contributed as a Startup Launch Associate. Max began a career at Pfizer in 2019 as a Project Associate. Max holds a Bachelor of Arts in Biology from the College of the Holy Cross and has a foundational education from St. John's Prep.